Skip to main content

1 July 2025

Last updated: Tuesday 1 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Bicycle Therapeutics developing highly specific and highly stable biopharmaceuticals

Wednesday 4 November 2009

Interviewee/Contributor

Regina Hodits

Organisation

Bicycle Therapeutics Ltd

Organisations

Standards Coordinating Body
Keck School of Medicine, University of Southern California
Arecor Therapeutics Plc
Max-Planck- Innovation GmbH
Oryx GmbH & Co KG and Valo Therapeutics Ltd
iTeos Therapeutics SA
TiGenix NV
MoonLake Immunotherapeutics AG
Mission Therapeutics
NDA Group

Interviewees and Contributers

Mark Vaeck
Graham Burnett-Hall
Bruno Pagliara
Jan Fagerberg
Massimo Dominici
Carlos Buesa
Philippe Pouletty
Christian Jørgensen
Jennifer Schneider
Chris Parker

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form